{
    "id": 1628,
    "fullName": "KIT N505I",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KIT N505I lies within the Ig-like C2-type domain 5 (exon 9) of the Kit protein (UniProt.org). N505I results in constitutive phosphorylation of Kit, activation of downstream Akt and Erk, and is transforming in cell culture (PMID: 24317392).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 651,
                    "pubMedId": 24317392,
                    "title": "A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24317392"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3815,
        "geneSymbol": "KIT",
        "terms": [
            "KIT",
            "C-Kit",
            "CD117",
            "MASTC",
            "PBT",
            "SCFR"
        ]
    },
    "variant": "N505I",
    "createDate": "09/08/2014",
    "updateDate": "05/15/2019",
    "referenceTranscriptCoordinates": {
        "id": 136458,
        "transcript": "NM_000222",
        "gDna": "chr4:g.54726024A>T",
        "cDna": "c.1514A>T",
        "protein": "p.N505I",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 991,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib) decreased phosphorylation of KIT, AKT, and ERK in melanocytes expressing KIT N505I in culture (PMID: 24317392).",
            "molecularProfile": {
                "id": 1642,
                "profileName": "KIT N505I"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 651,
                    "pubMedId": 24317392,
                    "title": "A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24317392"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 990,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, KIT N505I induced phosphorylation of KIT, ERK, and AKT, and was inhibited by Nexavar (sorafenib) in cell culture of melanocytes, demonstrating sensitivity of N505I to sorafenib (PMID: 24317392).",
            "molecularProfile": {
                "id": 1642,
                "profileName": "KIT N505I"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 651,
                    "pubMedId": 24317392,
                    "title": "A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24317392"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1642,
            "profileName": "KIT N505I",
            "profileTreatmentApproaches": [
                {
                    "id": 107,
                    "name": "KIT Inhibitor",
                    "profileName": "KIT N505I"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 136461,
            "transcript": "XM_017008180",
            "gDna": "chr4:g.54726024A>T",
            "cDna": "c.1514A>T",
            "protein": "p.N505I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136460,
            "transcript": "XM_017008178",
            "gDna": "chr4:g.54726024A>T",
            "cDna": "c.1514A>T",
            "protein": "p.N505I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136458,
            "transcript": "NM_000222",
            "gDna": "chr4:g.54726024A>T",
            "cDna": "c.1514A>T",
            "protein": "p.N505I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136459,
            "transcript": "NM_001093772",
            "gDna": "chr4:g.54726024A>T",
            "cDna": "c.1514A>T",
            "protein": "p.N505I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}